A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

计划入组 263 人 · 首次发布于 2024 年 1 月 31 日

Safety Study of ALG- 1001 to Treat Diabetic Macular Edema

首次发布于 2011 年 12 月 1 日

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

计划入组 308 人 · 首次发布于 2013 年 8 月 21 日

CUSP06

M-1001

ORE-1001

C₁₉H₂₃Cl₂N₃O₄

Caprock Mining Corp

United States

DREXEL UNIVERSITY

United States

浙江章光101有限公司

FDA Grants Fast Track Status to OnCusp's Novel Antibody-Drug Conjugate for Platinum-Resistant Ovarian Cancer

OnCusp's CDH6-Directed ADC CUSP06 Shows 36% Response Rate in Platinum-Resistant Ovarian Cancer

DemeRx Receives FDA Clearance for Novel Neuroplastogen DMX-1001 to Treat Alcohol Use Disorder